Patent Yard Sign in
Canadian application, no grantCanada

Trifluoromethyl analogs of fucose and uses thereof

CA 2106785 A1 · Owner: Biomembrane Institute (The) · Inventors: Hakomori, Sen-Itiroh; Toyokuni, Tatsushi

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention discloses trifluorofucoses and methods of making the same. Also disclosed are trifluorofucose analogs of fucose-containing oligosaccharides, and conjugates of trifluorofucose. The compounds of the present invention may be used in the manufacture of a medicament. Compositions are prepared which combine the trifluorofucose-containing oligosaccharides or trifluorofucose conjugates of the present invention with a pharmaceutically acceptable carrier or diluent. Tumor cell metastasis autoimmune, responses or initiation of an inflammatory process may be inhibited by such compositions.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 29, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 29, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 29, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 29, 1992
GrantedNo grant recorded
Term endedApril 29, 2012
Patent numberCA 2106785 A1
Classification (IPC)C07H15/10 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedApril 29, 1992Term endedApril 29, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.